AbCellera Biologics (ABCL) Goodwill & Intangibles (2020 - 2026)
AbCellera Biologics' (ABCL) quarterly Goodwill & Intangibles came in at $85.3 million in Q1 2026, down 4.19% YoY from $89.0 million in Q1 2025, and down 1.07% on a QoQ basis from $86.2 million in Q4 2025.
AbCellera Biologics (ABCL) Goodwill & Intangibles (2020 - 2026) Analysis & Trends
AbCellera Biologics (ABCL) has 7 years of Goodwill & Intangibles data on file, last reported at $85.3 million in Q1 2026.
- Quarterly Goodwill & Intangibles fell 4.19% year-over-year to $85.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $85.3 million (down 4.19% YoY) and the FY2025 annual result came in at $86.2 million, down 4.15% from the prior year.
- Goodwill & Intangibles declined to $85.3 million in Q1 2026, from $86.2 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $208.8 million in Q1 2022 to a low of $85.3 million in Q1 2026.
- A 5-year average of $140.4 million and a median of $166.5 million in 2024 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2022 — Goodwill & Intangibles surged 549.53% — and 2025, when it slumped 46.56%.
- Tracing ABCL's Goodwill & Intangibles over 5 years: stood at $179.3 million in 2022, then fell by 6.18% to $168.2 million in 2023, then plunged by 46.55% to $89.9 million in 2024, then dropped by 4.15% to $86.2 million in 2025, then decreased by 1.07% to $85.3 million in 2026.
- The last three Goodwill & Intangibles figures came in at $85.3 million (Q1 2026), $86.2 million (Q4 2025), and $87.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | AbCellera Biologics | 3.49 Bn | 3.49 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 84.34 Mn |
| Mar 31, 2026 | 85.27 Mn |
| Dec 31, 2025 | 86.19 Mn |
| Sep 30, 2025 | 87.13 Mn |
| Jun 30, 2025 | 88.07 Mn |
| Mar 31, 2025 | 89.00 Mn |
| Dec 31, 2024 | 89.92 Mn |
| Sep 30, 2024 | 100.38 Mn |
| Jun 30, 2024 | 133.47 Mn |
| Mar 31, 2024 | 166.54 Mn |
| Dec 31, 2023 | 168.23 Mn |
| Sep 30, 2023 | 171.88 Mn |
| Jun 30, 2023 | 174.55 Mn |
| Mar 31, 2023 | 176.65 Mn |
| Dec 31, 2022 | 179.31 Mn |
| Sep 30, 2022 | 190.35 Mn |
| Jun 30, 2022 | 190.99 Mn |
| Mar 31, 2022 | 208.78 Mn |
| Dec 31, 2021 | 27.61 Mn |
| Sep 30, 2021 | 208.23 Mn |